Search Results 1-10 of 16459 for Huntington's+disease

  1. Huntington's disease - Symptoms and causes - Mayo Clinic

    Huntington's disease causes nerve cells in the brain to decay over time. The disease affects a person's movements, thinking ability and mental health.

  2. Huntington's disease - Diagnosis and treatment - Mayo Clinic

    Diagnosis · Neurological exam · Neuropsychological testing · Mental health evaluation · Brain-imaging and function tests · Genetic counseling and testing · Predictive ...

  3. Huntington's disease - Care at Mayo Clinic

    Advanced diagnosis and treatment. Mayo Clinic doctors have expertise and experience in evaluating and treating people with Huntington's disease and other ...

  4. Huntington's Disease Clinical Trials - Mayo Clinic Research

    This study is a 26 week, randomized, parallel group, double blind comparison of PF-02545920 5 mg, PF-02545920 20 mg, and placebo dosed BID in the treatment of ...

  5. Huntington's disease - Doctors and departments - Mayo Clinic

    This rare disease causes an early decay of nerve cells in the brain. Learn about its symptoms and how treatments may help.

  6. Alzheimer's disease - Symptoms and causes - Mayo Clinic

    Understand more about this brain disease that is the most common cause of dementia. Also learn about new tests and medicines.

  7. Parkinson's disease - Symptoms and causes - Mayo Clinic

    This causes movement problems and other symptoms of Parkinson's disease ... Alpha-synuclein seed amplification and its uses in Parkinson's disease. ... Caproni S, ...

  8. Parkinson's disease - Diagnosis and treatment - Mayo Clinic

    This test, also called an alpha-synuclein seed amplification assay, detects Parkinson's disease before symptoms begin. Alpha-synuclein clumps are a hallmark ...

  9. Randomized, Placebo Controlled Study Of The Efficacy And Safety Of PF-02545920 In Subjects With Huntington's Disease - Mayo Clinic

    Primary endpoint is the change from baseline in the Total Motor Score (TMS) assessment of the Unified Huntington Disease Rating Scale (UHDRS) after 26 weeks of ...

  10. A Study to Investigate the Long Term Safety, Tolerability And Effectiveness of Pf-02545920 in Subjects with Huntington's Disease Who Completed Study A8241021 - Mayo Clinic

    Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines ...